Psilocybe mushrooms, psilocybin & psilocin



Jump to:

Page 2

Vanhaelen-Fastré & Vanhaelen (1984). Qualitative and quantitative determinations of hallucinogenic components of psilocybe mushrooms by reversed-phase high-performance liquid chromatography. Journal of Chromatography.

Casale (1985). An aqueous-organic extraction method for the isolation and identification of psilocin from hallucinogenic mushrooms. Journal of Forensic Sciences.

Kysilka et al. (1985). High-performance liquid chromatographic determination of hallucinogenic indoleamines with simultaneous UV photometric and voltammetric detection. Journal of Chromatography.

Lee (1985). A technique for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms. Journal of Forensic Science.

Stijve, Klan & Kuyper (1985). Occurrence of psilocybin and baeocystin in the genus Inocybe. Persoonia.

Thompson et al. (1985). Mushroom use by college students. Journal of Drug Education.

Stijve & Kuyper (1986). Occurrence of psilocybin in various higher fungi from several european countries. Nestle Research News.

Gartz (1987). Occurrence of psilocybin and baeocystin in fruit bodies of Pluteus salicinus.

Ohenoja et al. (1987). The occurrence of psilocybin and psilocin in Finnish fungi. Journal of Natural Products.

Musha et al. (1988). [Poisoning by the hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes)--with special reference to subjective experiences during psilocybin poisoning]. Seishin Shinkeigaku Zasshi.

Schwartz & Smith (1988). Hallucinogenic mushrooms. Clinical Pediatrics.

Eivindvik, Rasmussen & Sund (1989). Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon. Acta Pharmaceutica Nordica.

Gartz (1989). Occurrence of psilocybin, psilocin and baeocystin in Gymnopilus purpuratus. Persoonia.

Gartz (1989). Biotransformation of tryptamine in fruiting mycelia of Psilocybe cubensis. Planta Medica.

Gartz (1989). Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe. Journal of Basic Microbiology.

Kysilka & Wurst (1989). High-performance liquid chromatographic determination of some psychotropic indole derivatives. Journal of Chromatography.

Kysilka (1990). Determination of psilocin in rat urine by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography.

Kysilka & Wurst (1990). A novel extraction procedure for psilocybin and psilocin determination in mushroom samples. Planta Medica.

Lassen, Ravn & Lassen (1990). [Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms]. Ugeskrift for Laeger.

Allen & Merlin (1992). Psychoactive mushroom use in Koh Samui and Koh Pha-Ngan, Thailand. Journal of Ethnopharmacology.

Lassen, Lassen & Skov (1992). [Consumption of psilocybin-containing hallucinogenic mushrooms by young people]. Ugeskrift for Laeger.

Raff, Halloran & Kjellstrand (1992). Renal failure after eating "magic" mushrooms. CMAJ.

Gable (1993). Skinner, Maslow, and psilocybin. Journal of Humanistic Psychology.

Lassen, Lassen & Skov (1993). [Hallucinogenic psilocybine-containing mushrooms. Patterns of use among Danish abusers]. Ugeskrift for Laeger.

Merlin & Allen (1993). Species identification and chemical analysis of psychoactive fungi in the Hawaiian islands. Journal of Ethnopharmacology.

Gartz (1994). Extraction and analysis of indole derivatives from fungal biomass. Journal of Basic Microbiology.

Gartz, Allen & Merlin (1994). Ethnomycology, biochemistry, and cultivation of Psilocybe samuiensis Guzmán, Bandala and Allen, a new psychoactive fungus from Koh Samui, Thailand. Journal of Ethnopharmacology.

Marcano et al. (1994). Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes. Journal of Ethnopharmacology.

Bergman & Karlsson (1995). [A caution for psilocybine in wild mushrooms. A young addict acquired acute delirium].

Hanes (1996). Serotonin, psilocybin, and body dysmorphic disorder: a case report. Journal of Clinical Psychopharmacology.

Spitzer et al. (1996). Increased activation of indirect semantic associations under psilocybin. Biological Psychiatry.

Babakhanian et al. (1997). [The toxicological aspects of poisonings by psilocybine-containing mushrooms]. Sudebno-Meditsinskaia Ekspertiza.

Franz et al. (1996). Magic mushrooms: hope for a 'cheap high' resulting in end-stage renal failure. Nephrology, Dialysis, Transplantation.

Hasler et al. (1997). Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharmaceutica Acta Helvetiae.

Holm et al. (1997). [Hallucinogenic mushrooms in Denmark]. Ugeskrift for Laeger.

Moreno & Delgado (1997). Hallucinogen-induced relief of obsessions and compulsions. The American Journal of Psychiatry.

Pedersen-Bjergaard (1997). Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis. Journal of Chromatography.

Vollenweider (1997). Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology.

Babakhanian et al. (1998). [The forensic chemical study of psilocybine-containing fungi]. Sudebno-Meditsinskaia Ekspertiza.

Beck et al. (1998). Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions. Journal of Analytical Toxicology.

Bogusz et al. (1998). Honey with Psilocybe mushrooms: a revival of a very old preparation on the drug market? International Journal of Legal Medicine.

Borowiak et al. (1998). Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction. Journal of Toxicology.

Doblin (1998). Dr. Leary's Concord Prison Experiment: A 34-year follow-up study. Journal of Psychoactive Drugs.

Gouzoulis-Mayfrank et al. (1998). Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans. Behavioural Pharmacology.

Gouzoulis-Mayfrank et al. (1998). Methodological issues of human experimental research with hallucinogens. Pharmacopsychiatry.

Metzner (1998). Reflections on the Concord Prison project and the follow-up study. Journal of Psychoactive Drugs.

Pedersen-Bjergaard et al. (1998). Strategies for the capillary electrophoretic separation of indole alkaloids in Psilocybe semilanceata. Electrophoresis.

Vollenweider et al. (1998). Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport.

Babakhanian et al. (1999). [The morphofunctional changes in the internal organs in the modelling of poisonings by psilocybine-containing mushrooms]. Sudebno-Meditsinskaia Ekspertiza.

Gouzoulis-Mayfrank (1999). Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacology.

Gouzoulis-Mayfrank (1999). Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study. Psychopharmacology.

Keller et al. (1999). Analysis of psilocybin and psilocin in Psilocybe subcubensis Guzmán by ion mobility spectrometry and gas chromatography-mass spectrometry. Forensic Science International.